| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.511 | 54.038 | 146.784 | 259.548 | 343.503 |
| Total Income - EUR | - | - | - | - | - | 1.511 | 54.329 | 150.496 | 264.404 | 346.713 |
| Total Expenses - EUR | - | - | - | - | - | 1.287 | 51.154 | 91.784 | 165.730 | 228.711 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 225 | 3.174 | 58.712 | 98.674 | 118.002 |
| Net Profit/Loss - EUR | - | - | - | - | - | 179 | 2.598 | 57.637 | 96.795 | 108.120 |
| Employees | - | - | - | - | - | 0 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Victoria Medestet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 1.112 | 36.237 | 66.055 | 91.202 | 72.166 |
| Current Assets | - | - | - | - | - | 8.491 | 17.557 | 30.436 | 67.062 | 65.088 |
| Inventories | - | - | - | - | - | 5.310 | 772 | 898 | 9.987 | 12.520 |
| Receivables | - | - | - | - | - | 1.752 | 12.754 | 13.394 | 12.007 | 23.672 |
| Cash | - | - | - | - | - | 1.430 | 4.031 | 16.143 | 45.068 | 28.896 |
| Shareholders Funds | - | - | - | - | - | 221 | 2.814 | 63.566 | 141.974 | 108.169 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 9.424 | 50.980 | 32.924 | 16.291 | 29.086 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Victoria Medestet S.r.l.